当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 现金流量表

康泰医学

(300869)

  

流通市值:34.10亿  总市值:51.87亿
流通股本:2.64亿   总股本:4.02亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金126,491,559.89492,702,503.02361,874,584.12232,338,810.43
  收到的税费返还63,795.926,879,099.438,639,820.675,543,420.95
  收到其他与经营活动有关的现金5,410,228.9122,708,744.1517,941,846.6911,060,774.32
  经营活动现金流入小计131,965,584.72522,290,346.6388,456,251.48248,943,005.7
  购买商品、接受劳务支付的现金34,458,004.08187,492,578.21133,084,073.5581,881,272.86
  支付给职工以及为职工支付的现金44,233,625178,053,039.89131,325,164.2584,973,934.19
  支付的各项税费4,777,776.2714,623,229.8620,316,927.2510,183,845.01
  支付其他与经营活动有关的现金21,868,904.7119,834,055.3284,129,192.8646,008,502.48
  经营活动现金流出小计105,338,310.05500,002,903.28368,855,357.91223,047,554.54
  经营活动产生的现金流量净额26,627,274.6722,287,443.3219,600,893.5725,895,451.16
二、投资活动产生的现金流量:
  收回投资收到的现金664,822,958.734,027,202,478.33490,000,000230,000,000
  取得投资收益收到的现金21,661,735.8552,270,604.6522,026,863.8511,087,403.34
  处置固定资产、无形资产和其他长期资产收回的现金净额-143,029.232,000-
  收到的其他与投资活动有关的现金150,000,000-2,472,924,300.242,265,405,327.86
  投资活动现金流入小计836,484,694.584,079,616,112.182,984,983,164.092,506,492,731.2
  购建固定资产、无形资产和其他长期资产支付的现金3,915,426.5949,477,794.1532,769,079.822,949,291.24
  投资支付的现金794,887,959.053,802,349,675.03950,000,000700,000,000
  支付其他与投资活动有关的现金-01,968,008,573.241,770,409,523.84
  投资活动现金流出小计798,803,385.643,851,827,469.182,950,777,653.042,493,358,815.08
  投资活动产生的现金流量净额37,681,308.94227,788,64334,205,511.0513,133,916.12
三、筹资活动产生的现金流量:
  取得借款收到的现金25,000,000275,000,000227,000,000165,000,000
  收到其他与筹资活动有关的现金-22,058,194.4422,010,00022,010,000
  筹资活动现金流入小计25,000,000297,058,194.44249,010,000187,010,000
  偿还债务支付的现金15,424,150.37120,000,00090,000,00060,000,000
  分配股利、利润或偿付利息支付的现金1,274,594.39112,108,790.19110,878,192.68101,568,436
  支付其他与筹资活动有关的现金706,467.961,428,776.251,394,382.229,519,302.1
  筹资活动现金流出小计17,405,212.72233,537,566.44202,272,574.9171,087,738.1
  筹资活动产生的现金流量净额7,594,787.2863,520,62846,737,425.115,922,261.9
四、汇率变动对现金及现金等价物的影响-13,346,067.85-15,181,674.71-6,992,635.8-1,792,124.01
五、现金及现金等价物净增加额58,557,303.04298,415,039.6193,551,193.9253,159,505.17
  加:期初现金及现金等价物余额982,722,811.09684,307,771.48684,307,771.48684,307,771.48
  期末现金及现金等价物余额1,041,280,114.13982,722,811.09777,858,965.4737,467,276.65
补充资料:
  净利润--24,423,861.05-16,937,573.17
  资产减值准备-28,148,237.76-16,022,591.5
  固定资产和投资性房地产折旧-23,346,261.61-11,631,377.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-21,425,276.04-9,612,176.19
    投资性房地产折旧-1,920,985.57-2,019,201.67
  无形资产摊销-2,372,292.95-1,179,849.12
  长期待摊费用摊销-23,994.45-40,943.76
  递延收益摊销--721,533--393,676.33
  处置固定资产、无形资产和其他长期资产的损失-166,264.31-11,244.08
  固定资产报废损失---0
  公允价值变动损失--1,773,267.48--2,752,724.31
  财务费用-20,228,674.56-4,117,441.13
  投资损失--16,729,120.38--849,480.1
  递延所得税--3,450,196.45--1,393,102.02
  其中:递延所得税资产减少--3,361,859.4--1,298,322.66
    递延所得税负债增加--88,337.05--94,779.36
  存货的减少-14,593,917.37--21,974,341.72
  经营性应收项目的减少--10,461,192.21--7,860,342
  经营性应付项目的增加--10,716,107.01-10,329,532.41
  现金的期末余额-982,722,811.09-737,467,276.65
  减:现金的期初余额-684,307,771.48-684,307,771.48
  现金及现金等价物的净增加额-298,415,039.61-53,159,505.17
公告日期2026-04-282026-04-282025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑